Clinical Trials Browser

Phase 1 × Lymphoma, T-Cell × veliparib × Clear all

NCT03061188 2024-06-12

Phase I/Ib Study of Nivolumab & Veliparib in Patients With Advanced Solid Tumors & Lymphoma

Phase 1 Completed

15 enrolled 18 charts

Lymphoma, T-Cell, Lymphoma, Mantle-Cell